BRUNS INGMAR (Chief Medical Officer) sold 9.0% of their position (3.30K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $8.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/10/2026ACC: 0001838041-26-000004
Officer· Chief Medical Officer
Since Feb 2026
-3.30K
Net shares
Net seller
$8.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.96K
Price / share
$2.43
Trade value
$7.20K
% of position
8.1%
2/6/2026
36.63K→33.67K
Common Stock
Direct
Shares
−335.00
Price / share
$2.39
Trade value
$801.62
% of position
1.0%
2/9/2026
33.67K→33.33K
Total
Net shares
−3.30K
Net value
-$8K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | S · Sale | −2.96K | $2.43 | $7.20K | 8.1% | 36.63K | 33.67K |
| Common Stock Direct | 2/9/2026 | S · Sale | −335.00 | $2.39 | $801.62 | 1.0% | 33.67K | 33.33K |
| Total | −3.30K | -$8K | ||||||
Derivative Transactions0
No derivative transactions reported